{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T14:44:01Z","timestamp":1754145841479,"version":"3.41.2"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,17]]},"DOI":"10.7759\/cureus.88162","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T14:33:53Z","timestamp":1752762833000},"source":"Crossref","is-referenced-by-count":0,"title":["Side Effects Associated With Respiratory Syncytial Virus Prefusion F (RSVpreF) Maternal Vaccination: A Scoping Review"],"prefix":"10.7759","author":[{"given":"Mabel","family":"Palmero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto A","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Olson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsey","family":"Millares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Macey","family":"Melinek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delaney","family":"Waggoner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caitlin","family":"Higginbotham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alia E","family":"Gali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophia M","family":"Kershner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph S","family":"De Gaetano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Respiratory syncytial virus (RSV). (2024). Accessed. August 30, 2024: https:\/\/www.niaid.nih.gov\/diseases-conditions\/respiratory-syncytial-virus-rsv."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.36342","article-title":"Respiratory syncytial virus: a comprehensive review of transmission, pathophysiology, and manifestation","volume":"15","author":"Kaler J","year":"2023","unstructured":"Kaler J, Hussain A, Patel K, Hernandez T, Ray S. Respiratory syncytial virus: a comprehensive review of transmission, pathophysiology, and manifestation. Cureus. 2023, 15:e36342. 10.7759\/cureus.36342","journal-title":"Cureus"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30938-8","article-title":"Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study","volume":"390","author":"Shi T","year":"2017","unstructured":"Shi T, McAllister DA, O'Brien KL, et al.. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study. Lancet. 2017, 390:946-58. 10.1016\/S0140-6736(17)30938-8","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1586\/erv.11.120","article-title":"Respiratory syncytial virus vaccine development","volume":"10","author":"Hurwitz JL","year":"2011","unstructured":"Hurwitz JL. Respiratory syncytial virus vaccine development. Expert Rev Vaccines. 2011, 10:1415-33. 10.1586\/erv.11.120","journal-title":"Expert Rev Vaccines"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s40272-023-00598-3","article-title":"Respiratory syncytial virus: a comprehensive review of transmission, pathophysiology, and manifestation","volume":"25","author":"Syed YY","year":"2023","unstructured":"Syed YY. Respiratory syncytial virus: a comprehensive review of transmission, pathophysiology, and manifestation. Paediatr Drugs. 2023, 25:729-34. 10.1007\/s40272-023-00598-3","journal-title":"Paediatr Drugs"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.04.098","article-title":"Clinical characteristics and outcomes of respiratory syncytial virus infection in pregnant women","volume":"37","author":"Hause AM","year":"2019","unstructured":"Hause AM, Avadhanula V, Maccato ML, et al.. Clinical characteristics and outcomes of respiratory syncytial virus infection in pregnant women. Vaccine. 2019, 37:3464-71. 10.1016\/j.vaccine.2019.04.098","journal-title":"Vaccine"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3201\/eid2111.150497","article-title":"Maternal effects of respiratory syncytial virus infection during pregnancy","volume":"21","author":"Wheeler SM","year":"2015","unstructured":"Wheeler SM, Dotters-Katz S, Heine RP, Grotegut CA, Swamy GK. Maternal effects of respiratory syncytial virus infection during pregnancy. Emerg Infect Dis. 2015, 21:1951-5. 10.3201\/eid2111.150497","journal-title":"Emerg Infect Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiad449","article-title":"Burden of respiratory syncytial virus-associated acute respiratory infections during pregnancy","volume":"229","author":"Kenmoe S","year":"2024","unstructured":"Kenmoe S, Chu HY, Dawood FS, et al.. Burden of respiratory syncytial virus-associated acute respiratory infections during pregnancy. J Infect Dis. 2024, 229:S51-60. 10.1093\/infdis\/jiad449","journal-title":"J Infect Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0152015","article-title":"Clinical presentation and birth outcomes associated with respiratory syncytial virus infection in pregnancy","volume":"11","author":"Chu HY","year":"2016","unstructured":"Chu HY, Katz J, Tielsch J, et al.. Clinical presentation and birth outcomes associated with respiratory syncytial virus infection in pregnancy. PLoS One. 2016, 11:e0152015. 10.1371\/journal.pone.0152015","journal-title":"PLoS One"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy439","article-title":"Respiratory syncytial virus hospitalization during pregnancy in 4 high-income countries, 2010-2016","volume":"67","author":"Regan AK","year":"2018","unstructured":"Regan AK, Klein NP, Langley G, et al.. Respiratory syncytial virus hospitalization during pregnancy in 4 high-income countries, 2010-2016. Clin Infect Dis. 2018, 67:1915-8. 10.1093\/cid\/ciy439","journal-title":"Clin Infect Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)00811-5","article-title":"Respiratory syncytial virus infection during infancy and asthma during childhood in the USA (INSPIRE): a population-based, prospective birth cohort study","volume":"401","author":"Rosas-Salazar C","year":"2023","unstructured":"Rosas-Salazar C, Chirkova T, Gebretsadik T, et al.. Respiratory syncytial virus infection during infancy and asthma during childhood in the USA (INSPIRE): a population-based, prospective birth cohort study. Lancet. 2023, 401:1669-80. 10.1016\/S0140-6736(23)00811-5","journal-title":"Lancet"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1177\/0300985814520639","article-title":"The relationship between respiratory syncytial virus and asthma","volume":"52","author":"Knudson CJ","year":"2015","unstructured":"Knudson CJ, Varga SM. The relationship between respiratory syncytial virus and asthma. Vet Pathol. 2015, 52:97-106. 10.1177\/0300985814520639","journal-title":"Vet Pathol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-020-00390-7","article-title":"Socioeconomic impact of RSV hospitalization","volume":"10","author":"Young M","year":"2021","unstructured":"Young M, Smitherman L. Socioeconomic impact of RSV hospitalization. Infect Dis Ther. 2021, 10:35-45. 10.1007\/s40121-020-00390-7","journal-title":"Infect Dis Ther"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2022.10.001","article-title":"Development of mRNA vaccines against respiratory syncytial virus (RSV)","volume":"68","author":"Qiu X","year":"2022","unstructured":"Qiu X, Xu S, Lu Y, Luo Z, Yan Y, Wang C, Ji J. Development of mRNA vaccines against respiratory syncytial virus (RSV). Cytokine Growth Factor Rev. 2022, 68:37-53. 10.1016\/j.cytogfr.2022.10.001","journal-title":"Cytokine Growth Factor Rev"},{"key":"ref15","article-title":"Respiratory syncytial virus prefusion F (RSVPreF3) vaccine","author":"Awosika AO","year":"2024","unstructured":"Awosika AO, Patel P. Respiratory syncytial virus prefusion F (RSVPreF3) vaccine. StatPearls. StatPearls Publishin, Treasure Island, FL; 2024."},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz390","article-title":"Safety and immunogenicity of a respiratory syncytial virus fusion (F) protein nanoparticle vaccine in healthy third-trimester pregnant women and their infants","volume":"220","author":"Mu\u0148oz FM","year":"2019","unstructured":"Mu\u0148oz FM, Swamy GK, Hickman SP, et al.. Safety and immunogenicity of a respiratory syncytial virus fusion (F) protein nanoparticle vaccine in healthy third-trimester pregnant women and their infants. J Infect Dis. 2019, 220:1802-15. 10.1093\/infdis\/jiz390","journal-title":"J Infect Dis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiad024","article-title":"Safety and immunogenicity of an investigational respiratory syncytial virus vaccine (RSVPreF3) in mothers and their infants: a phase 2 randomized trial","volume":"228","author":"Bebia Z","year":"2023","unstructured":"Bebia Z, Reyes O, Jeanfreau R, et al.. Safety and immunogenicity of an investigational respiratory syncytial virus vaccine (RSVPreF3) in mothers and their infants: a phase 2 randomized trial. J Infect Dis. 2023, 228:299-310. 10.1093\/infdis\/jiad024","journal-title":"J Infect Dis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe2401072","article-title":"Maternal RSV vaccine \u2014 weighing benefits and risks","volume":"390","author":"Rasmussen SA","year":"2024","unstructured":"Rasmussen SA, Jamieson DJ. Maternal RSV vaccine \u2014 weighing benefits and risks. N Engl J Med. 2024, 390:1050-1. 10.1056\/NEJMe2401072","journal-title":"N Engl J Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2305478","article-title":"RSV prefusion F protein-based maternal vaccine \u2014 preterm birth and other outcomes","volume":"390","author":"Dieussaert I","year":"2024","unstructured":"Dieussaert I, Hyung Kim J, Luik S, et al.. RSV prefusion F protein-based maternal vaccine \u2014 preterm birth and other outcomes. N Engl J Med. 2024, 390:1009-21. 10.1056\/NEJMoa2305478","journal-title":"N Engl J Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.p1021","article-title":"Maternal RSV vaccine: further analysis is urged on preterm births","volume":"381","author":"Boytchev H","year":"2023","unstructured":"Boytchev H. Maternal RSV vaccine: further analysis is urged on preterm births. BMJ. 2023, 381:1021. 10.1136\/bmj.p1021","journal-title":"BMJ"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7338a2","article-title":"Maternal respiratory syncytial virus vaccination and receipt of respiratory syncytial virus antibody (nirsevimab) by infants aged <8 months \u2014 United States, April 2024","volume":"73","author":"Razzaghi H","year":"2024","unstructured":"Razzaghi H, Garacci E, Kahn KE, et al.. Maternal respiratory syncytial virus vaccination and receipt of respiratory syncytial virus antibody (nirsevimab) by infants aged &lt;8 months \u2014 United States, April 2024. MMWR Morb Mortal Wkly Rep. 2024, 73:837-43. 10.15585\/mmwr.mm7338a2","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ogc.2023.02.013","article-title":"Vaccine hesitancy in women's health","volume":"50","author":"Spires B","year":"2023","unstructured":"Spires B, Brewton A, Maples JM, Ehrlich SF, Fortner KB. Vaccine hesitancy in women's health. Obstet Gynecol Clin North Am. 2023, 50:401-19. 10.1016\/j.ogc.2023.02.013","journal-title":"Obstet Gynecol Clin North Am"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2023.1260740","article-title":"Efficacy\u00a0and safety of respiratory syncytial virus vaccination during pregnancy to prevent lower respiratory tract illness in newborns and infants: a systematic review and meta-analysis of randomized controlled trials","volume":"11","author":"Ma J","year":"2023","unstructured":"Ma J, Chen L, Tang S, Shi Y. Efficacy\u00a0and safety of respiratory syncytial virus vaccination during pregnancy to prevent lower respiratory tract illness in newborns and infants: a systematic review and meta-analysis of randomized controlled trials. Front Pediatr. 2023, 11:1260740. 10.3389\/fped.2023.1260740","journal-title":"Front Pediatr"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.11124\/JBIES-21-00242","article-title":"Best practice guidance and reporting items for the development of scoping review protocols","volume":"20","author":"Peters MD","year":"2022","unstructured":"Peters MD, Godfrey C, McInerney P, et al.. Best practice guidance and reporting items for the development of scoping review protocols. JBI Evid Synth. 2022, 20:953-68. 10.11124\/JBIES-21-00242","journal-title":"JBI Evid Synth"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.7326\/M18-0850","article-title":"PRISMA Extension for Scoping Reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco AC","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, et al.. PRISMA Extension for Scoping Reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018, 169:467-73. 10.7326\/M18-0850","journal-title":"Ann Intern Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.11124\/JBIES-24-00103","article-title":"The revised JBI critical appraisal tool for the assessment of risk of bias for cohort studies","volume":"23","author":"Barker TH","year":"2025","unstructured":"Barker TH, Hasanoff S, Aromataris E, et al.. The revised JBI critical appraisal tool for the assessment of risk of bias for cohort studies. JBI Evid Synth. 2025, 23:441-53. 10.11124\/JBIES-24-00103","journal-title":"JBI Evid Synth"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.11124\/JBIES-22-00430","article-title":"The revised JBI critical appraisal tool for the assessment of risk of bias for randomized controlled trials","volume":"21","author":"Barker TH","year":"2023","unstructured":"Barker TH, Stone JC, Sears K, et al.. The revised JBI critical appraisal tool for the assessment of risk of bias for randomized controlled trials. JBI Evid Synth. 2023, 21:494-506. 10.11124\/JBIES-22-00430","journal-title":"JBI Evid Synth"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1908380","article-title":"Respiratory syncytial virus vaccination during pregnancy and effects in infants","volume":"383","author":"Madhi SA","year":"2020","unstructured":"Madhi SA, Polack FP, Piedra PA, et al.. Respiratory syncytial virus vaccination during pregnancy and effects in infants. N Engl J Med. 2020, 383:426-39. 10.1056\/NEJMoa1908380","journal-title":"N Engl J Med"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2106062","article-title":"Prefusion F protein-based respiratory syncytial virus immunization in pregnancy","volume":"386","author":"Sim\u00f5es EA","year":"2022","unstructured":"Sim\u00f5es EA, Center KJ, Tita AT, et al.. Prefusion F protein-based respiratory syncytial virus immunization in pregnancy. N Engl J Med. 2022, 386:1615-26. 10.1056\/NEJMoa2106062","journal-title":"N Engl J Med"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2216480","article-title":"Bivalent prefusion F vaccine in pregnancy to prevent RSV illness in infants","volume":"388","author":"Kampmann B","year":"2023","unstructured":"Kampmann B, Madhi SA, Munjal I, et al.. Bivalent prefusion F vaccine in pregnancy to prevent RSV illness in infants. N Engl J Med. 2023, 388:1451-64. 10.1056\/NEJMoa2216480","journal-title":"N Engl J Med"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.19268","article-title":"Nonadjuvanted bivalent respiratory syncytial virus vaccination and perinatal outcomes","volume":"7","author":"Son M","year":"2024","unstructured":"Son M, Riley LE, Staniczenko AP, et al.. Nonadjuvanted bivalent respiratory syncytial virus vaccination and perinatal outcomes. JAMA Netw Open. 2024, 7:e2419268. 10.1001\/jamanetworkopen.2024.19268","journal-title":"JAMA Netw Open"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2024.06.009","article-title":"Efficacy and safety of bivalent RSVpreF maternal vaccination to prevent RSV illness in Japanese infants: subset analysis from the pivotal randomized phase 3 MATISSE trial","volume":"42","author":"Otsuki T","year":"2024","unstructured":"Otsuki T, Akada S, Anami A, et al.. Efficacy and safety of bivalent RSVpreF maternal vaccination to prevent RSV illness in Japanese infants: subset analysis from the pivotal randomized phase 3 MATISSE trial. Vaccine. 2024, 42:126041. 10.1016\/j.vaccine.2024.06.009","journal-title":"Vaccine"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/368597-side-effects-associated-with-respiratory-syncytial-virus-prefusion-f-rsvpref-maternal-vaccination-a-scoping-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T14:33:54Z","timestamp":1752762834000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/368597-side-effects-associated-with-respiratory-syncytial-virus-prefusion-f-rsvpref-maternal-vaccination-a-scoping-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,17]]},"references-count":32,"URL":"https:\/\/doi.org\/10.7759\/cureus.88162","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,17]]}}}